Lu Wei, Xu Jin, Wang Hui-Ming, He Fu-Ming
Int J Oral Maxillofac Implants. 2018 May/Jun;33(3):661-670. doi: 10.11607/jomi.6213.
To verify whether lateral sinus floor elevation (LSFE) with the vertical height of the osteotomy decreased to 3 to 5 mm can achieve improvement compared with a conventional lateral window in terms of implant survival, graft stability, and related complications.
Of the 49 patients who were selected for inclusion in this retrospective study, 25 patients were in the test group and 24 were in the control group based on the vertical height of the lateral window. Each patient received the LSFE treatment using deproteinized bovine bone mineral (DBBM) based on the two different vertical heights of the lateral window (test group: 3 to 5 mm; control group: 6 to 8 mm in vertical height). Residual bone dimensions were measured preoperatively, and graft dimensions were measured immediately after the procedure (baseline), 6 months (T1), and 1 year (T2) postoperatively on the basis of cone beam computed tomography (CBCT) scans. CBCT scan data at the baseline were analyzed with image processing software to evaluate the volume of augmented material, and they were transformed into three-dimensional reconstruction images to calibrate the window dimension. Implant failure and recorded intraoperative and postoperative complications were counted.
A prominent augmented graft height was obtained in both groups (test group: 9.48 ± 3.27 mm; control group: 10.44 ± 3.01 mm) with no significant difference; likewise, no difference was observed concerning augmented graft volume. Neither cumulative survival rate (CSR) nor augmented graft height decrement had any statistical intergroup difference during each follow-up interval. CSRs were detected as 100% for the test group and 94.28% and 91.67% for the control group based on implants and patients, respectively. Intraoperative membrane perforation was reported in two cases with a few nosebleeds the first night in the test group, while one case occurred in the control group. All the perforations were successfully sealed intraoperatively by a collagen membrane.
Osteotomy of LSFE with decreased vertical height yielded similar results to the control group with conventional dimensions in terms of implant survival, graft stability, and related complications with 1 year of follow-up. Notwithstanding, a prospective split-mouth randomized controlled trial with long-term observation is imperative to further investigate the influence of decreased vertical height of the lateral window on maturation and consolidation of DBBM.
验证与传统侧窗术相比,截骨垂直高度降至3至5毫米的外侧鼻窦底提升术(LSFE)在种植体存留率、植骨稳定性及相关并发症方面是否能取得改善。
在入选本回顾性研究的49例患者中,根据侧窗的垂直高度,25例患者为试验组,24例为对照组。基于侧窗的两种不同垂直高度(试验组:3至5毫米;对照组:垂直高度6至8毫米),每位患者接受使用脱蛋白牛骨矿物质(DBBM)的LSFE治疗。术前测量剩余骨尺寸,并在术后即刻(基线)、术后6个月(T1)和1年(T2)基于锥形束计算机断层扫描(CBCT)测量植骨尺寸。使用图像处理软件分析基线时的CBCT扫描数据以评估植骨材料的体积,并将其转换为三维重建图像以校准窗口尺寸。统计种植体失败情况以及记录的术中及术后并发症。
两组均获得显著的植骨高度增加(试验组:9.48±3.27毫米;对照组:10.44±3.01毫米),差异无统计学意义;同样,在植骨体积增加方面未观察到差异。在每个随访间隔期间,累积存留率(CSR)和植骨高度减少均无组间统计学差异。基于种植体和患者,试验组的CSR分别检测为100%,对照组分别为94.28%和91.67%。试验组有2例报告术中膜穿孔,术后第一晚有少量鼻出血,而对照组有1例发生。所有穿孔均在术中通过胶原膜成功封闭。
随访1年,在种植体存留率、植骨稳定性及相关并发症方面,垂直高度降低的LSFE截骨术与传统尺寸的对照组结果相似。尽管如此,仍需进行一项长期观察的前瞻性双侧随机对照试验,以进一步研究侧窗垂直高度降低对DBBM成熟和巩固的影响。